Viewing Study NCT06675032


Ignite Creation Date: 2025-12-24 @ 9:57 PM
Ignite Modification Date: 2025-12-26 @ 6:27 PM
Study NCT ID: NCT06675032
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2024-11-05
First Post: 2024-11-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Clinical Trial of PCV24 in Children Aged 2 Months (Minimum 6 Weeks) to 17 Years
Sponsor: Shanghai Reinovax Biologics Co.,LTD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module